News tagged with allergan

Related topics: food and drug administration

Valeant planning hostile bid for Allergan

Valeant plans to take a buyout offer for Allergan directly to its shareholders this week, as the Botox maker continues to rebuff its proposals that have risen as high as $53 billion.

Jun 17, 2014
popularity not rated yet | comments 0

Valeant raises cash-stock offer for Allergan (Update)

Valeant Pharmaceuticals has pumped more cash into its bid for Botox maker Allergan, and it also defended its business model on Wednesday, a day after its reluctant acquisition target aired more concerns about ...

May 28, 2014
popularity not rated yet | comments 0

Valeant, Ackman make $45.6B Allergan bid

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

Apr 22, 2014
popularity not rated yet | comments 0

FDA approves new silicone breast implants

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

Jun 17, 2013
popularity 3 / 5 (1) | comments 0

FDA approves new silicone gel-filled breast implant

(HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years ...

Feb 21, 2013
popularity 5 / 5 (1) | comments 0

Allergan

Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.

This text uses material from Wikipedia licensed under CC BY-SA